Abstract
The authors provide a critical review focusing on pharmacotherapy of alcohol withdrawal syndrome in hospitalized patients who are not critically ill. They outline recommendations for patient assessment and monitoring.
Copyright © 2016 Cleveland Clinic.
MeSH terms
-
Adrenergic alpha-2 Receptor Agonists / therapeutic use
-
Adrenergic beta-Antagonists / therapeutic use
-
Alcohol Withdrawal Delirium / drug therapy*
-
Alcohol Withdrawal Seizures / drug therapy*
-
Anti-Dyskinesia Agents / therapeutic use
-
Anticonvulsants / therapeutic use
-
Barbiturates / therapeutic use
-
Benzodiazepines / therapeutic use*
-
Central Nervous System Depressants / therapeutic use
-
Ethanol / therapeutic use
-
Haloperidol / therapeutic use
-
Humans
-
Psychomotor Agitation / drug therapy*
-
Severity of Illness Index
-
Syndrome
Substances
-
Adrenergic alpha-2 Receptor Agonists
-
Adrenergic beta-Antagonists
-
Anti-Dyskinesia Agents
-
Anticonvulsants
-
Barbiturates
-
Central Nervous System Depressants
-
Benzodiazepines
-
Ethanol
-
Haloperidol